USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

“We’re just now gaining momentum and as some of these next generation designs of CAR T-cells start to show promise, I think that will lead to a flurry of further innovation.” Brentjens spent ...

The MINI Convertible family is all-new for a fourth generation in 2025, with three distinct models for North America: Cooper ...

and combination strategies is driving CAR T-cell therapy's expansion into broader treatment landscapes beyond oncology, paving the way for next-generation healthcare solutions. Global CAR T-Cell ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

While the first generation of CAR-T cells that have recently been approved in the US have proved to be highly effective, they are costly to make and administer. The CAR-T process involves several ...

In recent years, market players have been actively pursuing collaborations and partnerships with biotechnology and pharmaceutical companies to accelerate the development of next-generation CAR T-cell ...

Its pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.

UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing for an innovative CAR T-cell therapy for the treatment of paediatric acute lymphoblastic leukaemia LONDON & NEW YORK, April ...

Fourth Quarter 2024 Highlights and Recent ... Its pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited ...